MINNEAPOLIS, MN, USA (Press Release) - May 26, 2008 - Urologix®, Inc. (NASDAQ:ULGX) announced presentation of long-term clinical results from a multi-center trial with the Urologix Cooled ThermoCath® (CTC) Microwave Catheter for treatment of benign prostatic hyperplasia (BPH), also known as enlarged prostate, at the 2008 American Urological Association meeting in Orlando, Florida. CTC is a Cooled Thermotherapy catheter that is used exclusively with the Urologix CoolWave® or Targis® control units. The therapy is delivered in the comfortable setting of a physician's office with a treatment time of under 30 minutes. The results showed the efficacy of the CTC Microwave Catheter is durable for at least five years and the freedom from additional minimally invasive or surgical procedures is 90%. The data from the study showed clinically significant improvement from baseline of the three major BPH evaluation criteria: urinary flow rate, symptom improvement, and quality of life at the 5-year follow-up.

Alan Partin, MD, PhD, Chairman of the James Buchanan Brady Urological Institute at The Johns Hopkins Medical Institution, an investigator in the study, commented "Our long-term experience with the CTC Microwave Catheter demonstrated durability of response approaching conventional TURP and remarkable freedom from adverse events."

"Our support of this long term clinical trial is representative of our Company's commitment to science to better understand the benefits of the CTC Microwave Catheter for those affected by enlarged prostate disease. We believe these long term clinical results will aid physicians and patients in their decision making when weighing treatment options. This study demonstrates the effectiveness of the CTC Microwave Catheter in offering durable relief from symptoms of BPH for the majority of patients in a 30-minute treatment in a physician's office."

A complete review of the abstract along with a summary of the indications, contraindications, warnings and precautions of the treatment can be accessed at http://www.urologix.com.

Urologix®, Inc.

[ PRESS RELEASE ]

Please log-in or register in order to submit comments.

Powered by AkoComment!